EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Analysis of Predictive Factors for Arm Lymphedema Following Salvage Radiotherapy for Patients with Recurrent Breast Cancer

Hyunju Shin, Haeyoung Kim, Won Kyung Cho, Won Park, Nalee Kim, Ji Hye Hwang

Clinical Lymphology and Lymphedema · 2025-11 · 10 (2) · 53-62

DOI: 10.67326/cll.2025.10.2.53 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphology and Lymphedema, online erschienen am 29.11.2025. Verfasst von Hyunju Shin und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to identify clinical and dosimetric risk factors for subsequent arm lymphedema (SAL) in patients with locoregionally recurrent breast cancer who received salvage repeated radiotherapy (RT).

Methods

We retrospectively analyzed 65 patients treated between 2003 and 2017. Regional nodal areas were divided into seven subregions per Gross et al. (2019) and contoured for dosimetric evaluation. Initial and repeated RT plans were deformed and merged to calculate cumulative dose-volume histograms. Equivalent dose in 2 Gy fractions (EQD2)-based parameters (max dose, mean dose, min dose, percentage of volume receving at least n Gy (VnGy)) were assessed. Optimal cut points for dosimetric parameters were determined by maximally selected rank statistics. Multivariable Cox regression and Akaike information criterion (AIC) were applied to identify predictors of SAL.

Results

Salvage surgery was performed in 52% and taxane-based chemotherapy in 45%. Median accumulated prescription dose was 113.0 Gy EQD2. With a median follow-up of 30.4 months, 15 patients (23.1%) developed SAL after a median of 6.4 months. SAL was associated with taxane-based chemotherapy and higher doses to axillary-lateral thoracic junction (ALTJ) and adjacent regions. In multivariable analysis with clinical factors only, taxane-based chemotherapy was significant (HR 4.2, P=0.04). The final model with clinical and dosimetric parameters selected lateral to ALTJ V30Gy ≥60%(HR 5.35, P=0.001) plus taxane-based chemotherapy (HR 4.73, P=0.02).

Conclusion

SAL occurred in 23% of patients after salvage repeated RT. Taxane-based chemotherapy and lateral to ALTJ V30 Gy ≥60% were risk factors. Applying this dose constraint and early rehabilitation referral may help reduce SAL risk.

Zitieren

APA

Shin, H., Kim, H., Cho, W. K., Park, W., Kim, N., & Hwang, J. H. (2025). Analysis of Predictive Factors for Arm Lymphedema Following Salvage Radiotherapy for Patients with Recurrent Breast Cancer. Clinical Lymphology and Lymphedema, 10(2), 53-62. https://doi.org/10.67326/cll.2025.10.2.53

Vancouver

Shin H, Kim H, Cho WK, Park W, Kim N, Hwang JH. Analysis of Predictive Factors for Arm Lymphedema Following Salvage Radiotherapy for Patients with Recurrent Breast Cancer. Clinical Lymphology and Lymphedema. 2025;10(2):53-62. doi:10.67326/cll.2025.10.2.53

BibTeX
@article{Shin2025,
  author = {Shin, Hyunju and Kim, Haeyoung and Cho, Won Kyung and Park, Won and Kim, Nalee and Hwang, Ji Hye},
  title = {Analysis of Predictive Factors for Arm Lymphedema Following Salvage Radiotherapy for Patients with Recurrent Breast Cancer},
  journal = {Clinical Lymphology and Lymphedema},
  year = {2025},
  volume = {10},
  number = {2},
  pages = {53--62},
  doi = {10.67326/cll.2025.10.2.53}
}
Kostenlos starten →